Japão dá status de revisão prioritária ao medicamento para Alzheimer desenvolvido pela Eisai e Biogen
31 January 2023 - 5:26AM
Newspaper
/jornal/2023/01/japao-da-status-de-revisao-prioritaria-ao-medicamento-para-alzheimer-desenvolvido-pela-eisai-e-biogen/
Biogen DRN (BOV:BIIB34)
Historical Stock Chart
From May 2024 to Jun 2024
Biogen DRN (BOV:BIIB34)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Biogen DRN (Brazil Bovespa Exchange): 0 recent articles
More News Articles